During the projected period, the worldwide positron emission tomography (PET) scanners market is predicted to develop due to increased radiopharmaceutical use. Radiopharmaceuticals safely deliver radioactive isotopes within specified human tissues to assist medical imaging of malignancies. Gallium-68 is a radiopharmaceutical used in cancer detection.
Innovative radiotracer research and development are projected to provide market participants with appealing growth opportunities. In April 2020, for example, researchers at the University of Aveiro in Portugal discovered that pyrazole, an organic chemical, is an important scaffold for the manufacture of 18F-labeled radiotracers for PET imaging.
"The development of dual modality PET/CT and PET/MRI machines, which contribute to improved diagnostic sensitivity and specificity at each stage of illness prognosis, is a prominent trend in the worldwide Positron Emission Tomography (PET) scanners market." The introduction of novel radiopharmaceuticals has increased the diagnostic value of illness therapy, leading to a growing reliance on PET scanning technologies. In the following years, these trends are projected to dominate the global Positron Emission Tomography (PET) scanners market." - Healthcare, Pharmaceuticals, and Medical Devices Analyst, Coherent Market Insights